Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Initial Beneficial Ownership · 3

Anteris Technologies Global Corp.

AVRNASDAQEQUITYCurrent

Initial Beneficial Ownership

Filed Nov 4, 2026Accepted Nov 4, 2026, 6:02 AM ESTFiling CIK 2011514Accession 0001140361-26-041881
Share

Structured filing — 3

form3.xml

Open full document ↗

Filing details

Report period
2026-10-26
Issuer
Anteris Technologies Global Corp.
Issuer CIK
0002011514
Trading symbol
AVR
Foreign trading symbol
AVR
No securities owned
Checked

Reporting owner 1

Name
Schwartz Eric
Reporting owner CIK
0001329100
Relationship
Officer
Officer title
Chief Legal Officer
Address
TOOWONG TOWER, LEVEL 3, SUITE 302, 9 SHERWOOD ROAD, TOOWONG, AUSTRALIA, QUEENSLAND, C3, 4066

Signature 1

Signed
/s/ Eric Schwartz
Date
2026-11-03

Company context

Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) is a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Founded in Australia, with a significant presence in Minneapolis, USA, Anteris is a science-driven company with an experienced team of multidisciplinary professionals delivering restorative solutions to structural heart disease patients.

Current securities

Recent company filings

  1. Results of Operations and Financial ConditionNov 12, 2026
  2. 10-Q filingNov 10, 2026
  3. ARS filingNov 9, 2026
  4. DEF 14A filingNov 9, 2026
  5. 10-Q/A filingNov 9, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.